|
LILLY ELI & CO - 10-Q - 20051103 - EXHIBIT_INDEX
INDEX TO EXHIBITS
The following documents are filed as a part of this Report:
|
|
|
|
|
Exhibit
|
|
|
|
EXHIBIT 10.1
|
|
The Eli Lilly and Company Bonus Plan, as amended
|
|
|
|
|
|
EXHIBIT 10.2
|
|
Master Settlement Agreement regarding Zyprexa product liability claims*
|
|
|
|
|
|
EXHIBIT 11.
|
|
Statement re: Computation of Earnings (Loss) per Share
|
|
|
|
|
|
EXHIBIT 12.
|
|
Statement re: Computation of Ratio of Earnings From Continuing Operations to Fixed Charges
|
|
|
|
|
|
EXHIBIT 31.1
|
|
Rule 13a-14(a) Certification of Sidney Taurel, Chairman of the Board and Chief Executive Officer
|
|
|
|
|
|
EXHIBIT 31.2
|
|
Rule 13a-14(a) Certification of Charles E. Golden, Executive Vice President and Chief Financial Officer
|
|
|
|
|
|
EXHIBIT 32.
|
|
Section 1350 Certification
|
|
|
|
|
|
EXHIBIT 99.
|
|
Cautionary Statement Under Private Securities Litigation Reform Act of 1995 – “Safe Harbor” for Forward-Looking Disclosures
|
|
|
|
|
|
*
|
|
Portions of this exhibit have been omitted pursuant to a confidential treatment request to the
Securities and Exchange Commission.
|
27
|
|
Next Section
Previous Section